Pronounce: klo-FARE-a-been
Classification: Antimetabolite (purine analog)
Clofarabine is a purine nucleoside analog, which affects the DNA and RNA of leukemia cells. Clofarabine inhibits the growth of new cancer cells, stops them from dividing, and causes cell death.
Clofarabine is given intravenously (IV, into a vein). The dose is based on your size. The dose and how often you receive this chemotherapy will be determined by your care team.
You should not take any medications that can damage the kidneys or liver while taking clofarabine. Make sure to tell your provider about any medications, vitamins or supplements you may be taking.
There are a number of things you can do to manage the side effects of clofarabine. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
This medication can cause life threatening infections, with or without a decrease in white blood cell counts.
White blood cells (WBC) are important for fighting infection. While receiving treatment, your WBC count can drop, putting you at a higher risk of getting an infection. You should let your doctor or nurse know right away if you have a fever (temperature greater than 100.4°F or 38°C), sore throat or cold, shortness of breath, cough, burning with urination, or a sore that doesn't heal.
Tips to preventing infection:
Your red blood cells are responsible for carrying oxygen to the tissues in your body. When the red cell count is low, you may feel tired or weak. You should let your oncology care team know if you experience any shortness of breath, difficulty breathing or pain in your chest. If the count gets too low, you may receive a blood transfusion.
Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding and in rare cases with this medication it can lead to hemorrhage. Let your oncology care team know if you have any excess bruising or bleeding, including nose bleeds, bleeding gums or blood in your urine or stool. If the platelet count becomes too low, you may receive a transfusion of platelets.
Talk to your oncology care team so they can prescribe medications to help you manage nausea and vomiting. In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy/fatty, spicy or acidic foods (lemons, tomatoes, oranges). Try saltines, or ginger ale to lessen symptoms.
Call your oncology care team if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.
Diarrhea can be a sign of a serious complication called enterocolitis and can lead to serious dehydration. Symptoms of enterocolitis include diarrhea, nausea, vomiting, abdominal pain, fever, and chills. Be sure to report any diarrhea to your oncology team.
This medication can cause liver toxicity and in rare cases can cause venous occlusive disease. Venous occlusive disease is a blockage of the small veins in the liver. Your healthcare provider may monitor for liver toxicity using blood tests called liver function tests. Notify your healthcare provider if you notice yellowing of the skin or eyes, your urine appears dark or brown, accumulation of fluid in your belly, or pain in your abdomen, as these can be signs of liver toxicity or venous occlusive disease.
This medication can affect your kidney function. Your kidney function will be monitored throughout treatment. If you experience swelling of your face or body, or a decrease in the amount of urine you are producing, notify your healthcare team immediately.
Some patients will develop a rash, very dry or itchy skin, which can be managed with skin moisturizers and other topical treatments. However, a rare but serious skin reaction called Stevens Johnson Syndrome can occur, which affects the skin and mucous membranes (lining of mouth and nose). It typically starts as a rash or painful blisters and can progress to serious damage to the skin and in some cases, death. It is important that you report any rash to your healthcare providers immediately.
Your healthcare provider can recommend medications and other strategies to help relieve pain.
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your healthcare team for helpful tips on dealing with this side effect.
This medication can also cause tachycardia, or a higher than normal heart rate. Notify your care provider if you feel like your heart is racing, you become short of breath, dizzy, or faint.
Nutrition is an important part of your care. Cancer treatment can affect your appetite and, in some cases, the side effects of treatment can make eating difficult. Ask your oncology care team about nutritional counseling services at your treatment center to help with food choices.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. For women, effective birth control is necessary during treatment and for 6 months after the last dose. For men, effective birth control is necessary during treatment and for 3 months after the last dose. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should not breastfeed while receiving this medication and for 2 weeks after your last dose.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania